Cargando…
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Despite advances in the diagnostic and therapeutic modalities, the prognosis of several solid tumor malignancies remains poor. Different factors associated with solid tumors including a varied genetic signature, complex molecular signaling pathways, defective cross talk between the tumor cells and i...
Autores principales: | Nayyar, Gaurav, Chu, Yaya, Cairo, Mitchell S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378304/ https://www.ncbi.nlm.nih.gov/pubmed/30805309 http://dx.doi.org/10.3389/fonc.2019.00051 |
Ejemplares similares
-
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab
with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity
against GD2(+) pediatric solid tumors and in vivo survival of xenografted
immunodeficient NSG mice
por: Chu, Yaya, et al.
Publicado: (2021) -
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022) -
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer
por: Gemelli, Maria, et al.
Publicado: (2022) -
In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013) -
Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
por: Qin, Hong, et al.
Publicado: (2022)